APEA PREDICTOR EXAM Q&A 2026/2027
Warfarin, Screening & Diabetes/BP Guide | Advanced Practice Nursing Certification
Graded A+ | 100% Verified | Exam-Ready Format
Instructions: Select the best answer. Correct answers appear in bold cyan with evidence-based rationales
referencing current clinical guidelines (ACC/AHA, CHEST, ADA, USPSTF).
Section I: Anticoagulation Therapy (Warfarin)
1. Warfarin exerts its anticoagulant effect by inhibiting which vitamin-dependent clotting factors?
A. Factors II, VII, IX, and X
B. Factors V, VIII, IX, and XII
C. Factors I, II, V, and VII
D. Factors VII, VIII, X, and XIII
Correct Answer: A
Rationale: Warfarin inhibits vitamin K epoxide reductase (VKORC1), preventing the gamma-carboxylation
and subsequent activation of vitamin K-dependent clotting factors II (prothrombin), VII, IX, and X, as well
as the anticoagulant proteins C and S. This produces a therapeutic anticoagulant state monitored by the
INR.
2. A patient newly started on warfarin for atrial fibrillation should reach the target INR within
what timeframe?
A. 24-48 hours
B. 3-5 days with heparin bridge
C. 2-3 weeks
D. 6-8 weeks
Correct Answer: B
Rationale: Warfarin requires several days to achieve full therapeutic effect because it inhibits synthesis of
new clotting factors but does not affect already-circulating factors. Per CHEST 2021 guidelines, a heparin
or LMWH bridge is required for at least 5 days and until the INR is therapeutic (2.0-3.0 for AFib) for at
least 24 hours due to the transient prothrombotic state from protein C depletion.
,3. What is the target INR range for a patient with mechanical mitral valve replacement on
warfarin?
A. 1.5-2.0
B. 2.0-3.0
C. 2.5-3.5
D. 3.0-4.0
Correct Answer: C
Rationale: Per ACC/AHA 2020 valvular heart disease guidelines, patients with mechanical mitral valves
require a target INR of 2.5-3.5. Mechanical aortic valves require INR 2.0-3.0. The higher target for mitral
valves reflects the greater thromboembolic risk associated with mitral valve prostheses.
4. Which medication is the most clinically significant cytochrome P450 interaction that increases
INR when co-administered with warfarin?
A. Amoxicillin
B. Metronidazole
C. Lisinopril
D. Pantoprazole
Correct Answer: B
Rationale: Metronidazole is a potent CYP2C9 inhibitor. Warfarin is metabolized primarily by CYP2C9 (S-
enantiomer, the more active form) and CYP1A2/CYP3A4 (R-enantiomer). Inhibiting CYP2C9 reduces
warfarin clearance, significantly increasing INR and bleeding risk. The NP should monitor INR closely and
consider dose reduction when starting metronidazole.
5. A patient on warfarin presents with an INR of 8.5 without active bleeding. The most
appropriate initial management is:
A. Administer 4-factor prothrombin complex concentrate (4F-PCC)
B. Hold warfarin, administer oral vitamin K 2.5-5 mg
C. Administer fresh frozen plasma and hold warfarin
D. Continue warfarin at reduced dose and recheck INR in 1 week
Correct Answer: B
, Rationale: Per CHEST 2024 guidelines, for asymptomatic INR elevation above the therapeutic range
without bleeding: hold 1-2 doses, administer oral vitamin K 2.5-5 mg (particularly if INR > 10), and
recheck INR in 24-48 hours. 4F-PCC and FFP are reserved for life-threatening bleeding. Simply reducing
the dose is insufficient for an INR of 8.5.
6. Which dietary counseling is most important for a patient initiating warfarin therapy?
A. Eliminate all foods containing vitamin K entirely
B. Maintain consistent vitamin K intake rather than avoiding it
C. Avoid all green vegetables permanently
D. Take vitamin K supplements to stabilize INR
Correct Answer: B
Rationale: Consistent rather than restricted vitamin K intake is the cornerstone of dietary counseling.
Sudden changes in vitamin K consumption (eating large amounts of leafy greens after a period of
avoidance) cause unpredictable INR fluctuations. Patients should aim for consistent daily intake of
approximately 90-120 mcg/day of vitamin K.
7. Which of the following over-the-counter medications poses the greatest bleeding risk when
combined with warfarin?
A. Acetaminophen 500 mg
B. Ibuprofen 400 mg
C. Loratadine 10 mg
D. Omeprazole 20 mg
Correct Answer: B
Rationale: NSAIDs (ibuprofen) inhibit platelet function through COX-1 inhibition and cause
gastrointestinal mucosal damage, compounding warfarin's anticoagulant effect. The combination
significantly increases the risk of serious GI bleeding. Acetaminophen is preferred but may also increase
INR at doses exceeding 2 g/day. The NP should counsel patients to avoid all NSAIDs while on warfarin.
8. The antidote for warfarin overdose in the setting of life-threatening hemorrhage is:
A. Protamine sulfate
B. Vitamin K (phytonadione) IV
C. 4-Factor Prothrombin Complex Concentrate (4F-PCC)
D. Desmopressin (DDAVP)
Warfarin, Screening & Diabetes/BP Guide | Advanced Practice Nursing Certification
Graded A+ | 100% Verified | Exam-Ready Format
Instructions: Select the best answer. Correct answers appear in bold cyan with evidence-based rationales
referencing current clinical guidelines (ACC/AHA, CHEST, ADA, USPSTF).
Section I: Anticoagulation Therapy (Warfarin)
1. Warfarin exerts its anticoagulant effect by inhibiting which vitamin-dependent clotting factors?
A. Factors II, VII, IX, and X
B. Factors V, VIII, IX, and XII
C. Factors I, II, V, and VII
D. Factors VII, VIII, X, and XIII
Correct Answer: A
Rationale: Warfarin inhibits vitamin K epoxide reductase (VKORC1), preventing the gamma-carboxylation
and subsequent activation of vitamin K-dependent clotting factors II (prothrombin), VII, IX, and X, as well
as the anticoagulant proteins C and S. This produces a therapeutic anticoagulant state monitored by the
INR.
2. A patient newly started on warfarin for atrial fibrillation should reach the target INR within
what timeframe?
A. 24-48 hours
B. 3-5 days with heparin bridge
C. 2-3 weeks
D. 6-8 weeks
Correct Answer: B
Rationale: Warfarin requires several days to achieve full therapeutic effect because it inhibits synthesis of
new clotting factors but does not affect already-circulating factors. Per CHEST 2021 guidelines, a heparin
or LMWH bridge is required for at least 5 days and until the INR is therapeutic (2.0-3.0 for AFib) for at
least 24 hours due to the transient prothrombotic state from protein C depletion.
,3. What is the target INR range for a patient with mechanical mitral valve replacement on
warfarin?
A. 1.5-2.0
B. 2.0-3.0
C. 2.5-3.5
D. 3.0-4.0
Correct Answer: C
Rationale: Per ACC/AHA 2020 valvular heart disease guidelines, patients with mechanical mitral valves
require a target INR of 2.5-3.5. Mechanical aortic valves require INR 2.0-3.0. The higher target for mitral
valves reflects the greater thromboembolic risk associated with mitral valve prostheses.
4. Which medication is the most clinically significant cytochrome P450 interaction that increases
INR when co-administered with warfarin?
A. Amoxicillin
B. Metronidazole
C. Lisinopril
D. Pantoprazole
Correct Answer: B
Rationale: Metronidazole is a potent CYP2C9 inhibitor. Warfarin is metabolized primarily by CYP2C9 (S-
enantiomer, the more active form) and CYP1A2/CYP3A4 (R-enantiomer). Inhibiting CYP2C9 reduces
warfarin clearance, significantly increasing INR and bleeding risk. The NP should monitor INR closely and
consider dose reduction when starting metronidazole.
5. A patient on warfarin presents with an INR of 8.5 without active bleeding. The most
appropriate initial management is:
A. Administer 4-factor prothrombin complex concentrate (4F-PCC)
B. Hold warfarin, administer oral vitamin K 2.5-5 mg
C. Administer fresh frozen plasma and hold warfarin
D. Continue warfarin at reduced dose and recheck INR in 1 week
Correct Answer: B
, Rationale: Per CHEST 2024 guidelines, for asymptomatic INR elevation above the therapeutic range
without bleeding: hold 1-2 doses, administer oral vitamin K 2.5-5 mg (particularly if INR > 10), and
recheck INR in 24-48 hours. 4F-PCC and FFP are reserved for life-threatening bleeding. Simply reducing
the dose is insufficient for an INR of 8.5.
6. Which dietary counseling is most important for a patient initiating warfarin therapy?
A. Eliminate all foods containing vitamin K entirely
B. Maintain consistent vitamin K intake rather than avoiding it
C. Avoid all green vegetables permanently
D. Take vitamin K supplements to stabilize INR
Correct Answer: B
Rationale: Consistent rather than restricted vitamin K intake is the cornerstone of dietary counseling.
Sudden changes in vitamin K consumption (eating large amounts of leafy greens after a period of
avoidance) cause unpredictable INR fluctuations. Patients should aim for consistent daily intake of
approximately 90-120 mcg/day of vitamin K.
7. Which of the following over-the-counter medications poses the greatest bleeding risk when
combined with warfarin?
A. Acetaminophen 500 mg
B. Ibuprofen 400 mg
C. Loratadine 10 mg
D. Omeprazole 20 mg
Correct Answer: B
Rationale: NSAIDs (ibuprofen) inhibit platelet function through COX-1 inhibition and cause
gastrointestinal mucosal damage, compounding warfarin's anticoagulant effect. The combination
significantly increases the risk of serious GI bleeding. Acetaminophen is preferred but may also increase
INR at doses exceeding 2 g/day. The NP should counsel patients to avoid all NSAIDs while on warfarin.
8. The antidote for warfarin overdose in the setting of life-threatening hemorrhage is:
A. Protamine sulfate
B. Vitamin K (phytonadione) IV
C. 4-Factor Prothrombin Complex Concentrate (4F-PCC)
D. Desmopressin (DDAVP)
